Mesirow Financial Investment Management, Inc. Aldeyra Therapeutics, Inc. Transaction History

Mesirow Financial Investment Management, Inc.

$4.94 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$3.25 - $5.17 $158,310 - $251,835	-48,711 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$7.94 - $11.31 $10,726 - $15,279	-1,351 Reduced 2.7%	48,711 $428,000
Q2 2021 Jul 23, 2021	SELL	$10.44 - $14.85 $141,691 - $201,544	-13,572 Reduced 21.33%	50,062 $567,000
Q1 2021 Apr 14, 2021	SELL	$6.53 - $14.42 $6,947 - $15,342	-1,064 Reduced 1.64%	63,634 $756,000
Q4 2020 Jan 14, 2021	BUY	$6.31 - $8.13 $1,937 - $2,495	307 Added 0.48%	64,698 $443,000
Q3 2020 Oct 13, 2020	SELL	$4.0 - $7.53 $108,700 - $204,627	-27,175 Reduced 29.68%	64,391 $477,000
Q2 2020 Jul 22, 2020	SELL	$1.97 - $5.05 $4,525 - $11,599	-2,297 Reduced 2.45%	91,566 $382,000
Q1 2020 Apr 09, 2020	BUY	$1.62 - $6.4 $43,762 - $172,889	27,014 Added 40.41%	93,863 $232,000
Q4 2019 Jan 09, 2020	SELL	$4.73 - $7.98 $10,311 - $17,396	-2,180 Reduced 3.16%	66,849 $388,000
Q3 2019 Oct 30, 2019	BUY	$4.41 - $6.12 $27,752 - $38,513	6,293 Added 10.03%	69,029 $364,000
Q2 2019 Jul 12, 2019	BUY	$6.0 - $9.0 $40,650 - $60,975	6,775 Added 12.11%	62,736 $373,000
Q1 2019 Apr 09, 2019	BUY	$7.14 - $9.85 $127,548 - $175,960	17,864 Added 46.89%	55,961 $505,000
Q3 2018 Oct 09, 2018	SELL	$6.8 - $14.35 $20,610 - $43,494	-3,031 Reduced 7.37%	38,097 $526,000
Q2 2018 Jul 11, 2018	BUY	$6.95 - $9.18 $285,839 - $377,555	41,128 New	41,128 $327,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$50.6 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$29.9 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$20.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$19.8 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$10.3 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $318M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Account